Aetna executives are still not ready to say whether they will give up on their proposed $37 billion acquisition of Louisville-based Humana in the face of a federal judge’s order blocking the deal on antitrust grounds.
Aetna continues to evaluate whether it will appeal the Jan. 23 order, Aetna CEO Mark Bertolini told stock analysts on a conference call Tuesday.
The company will have to decide whether to abandon the deal or work out an extension with Humana by Feb. 15, the current deadline for the merger, Bertolini said.
“We’re going to take all of that time to make sure we have pursued all potential opportunities to either appeal or not,” Bertolini said. “…We are in no rush given that we are literally two weeks away from having to make that decision.”
If the deal is terminated, Aetna would owe Humana a $1 billion break-up fee.
The companies had planned to sell some of their business to Molina Healthcare for $117 million, but the proposal failed to allay the Justice Department and judge’s concerns about competition following the merger.
Full Content: WDRB
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
DOJ Antitrust Chief Gail Slater Assembles Veteran Team for Key Cases
Mar 16, 2025 by
CPI
UK Demands Access to Apple’s Encrypted Cloud Data, Spark Legal and Privacy Battle
Mar 16, 2025 by
CPI
Turkey Probes Netflix, Disney+, and Amazon Over Anti-Competitive Practices
Mar 16, 2025 by
CPI
Elon Musk and OpenAI Agree to Accelerate Trial Amidst Legal Battle Over AI’s For-Profit Shift
Mar 16, 2025 by
CPI
AI in Markets: A Double-Edged Sword for Competition, Says CCI Chief
Mar 16, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Self-Preferencing
Feb 26, 2025 by
CPI
Platform Self-Preferencing: Focusing the Policy Debate
Feb 26, 2025 by
Michael Katz
Weaponized Opacity: Self-Preferencing in Digital Audience Measurement
Feb 26, 2025 by
Thomas Hoppner & Philipp Westerhoff
Self-Preferencing: An Economic Literature-Based Assessment Advocating a Case-By-Case Approach and Compliance Requirements
Feb 26, 2025 by
Patrice Bougette & Frederic Marty
Self-Preferencing in Adjacent Markets
Feb 26, 2025 by
Muxin Li